This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides Are Peptides coming off of the FDA Category 2 list? A legal breakdown. After being placed into FDA Category 2 in 2023, several widely discussed peptides faced restricted pathways for regulated compounding. This shift pushed demand toward unregulated markets and created significant uncertainty across the RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals